Quick Answer
Modular Medical, Inc. reported Total Revenue of $0.00 for fiscal year 2018.
Modular Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$18.82M -7.8% |
-$17.47M -25.9% |
-$13.88M +25.5% |
-$18.63M -152.5% |
-$7.38M -38.7% |
-$5.32M -109.5% |
| Diluted EPS | -$0.51 +34.6% |
-$0.78 +32.2% |
-$1.15 +58.0% |
-$2.74 | — | — |
| Total Assets | $18.73M +35.7% |
$13.81M +90.6% |
$7.25M -26.4% |
$9.85M +338.0% |
$2.25M -41.7% |
$3.86M -42.0% |
| Cash and Equivalents | $13.10M +41.8% |
$9.23M +143.0% |
$3.80M -58.1% |
$9.08M +518.1% |
$1.47M -53.0% |
$3.12M -52.4% |
| Stockholders Equity | $17.08M +48.0% |
$11.54M +127.2% |
$5.08M -42.6% |
$8.84M +793.0% |
-$1.28M -144.3% |
$2.88M -55.5% |
| R&D Expense | $14.70M +14.1% |
$12.88M +42.1% |
$9.06M +17.2% |
$7.73M +89.3% |
$4.08M +34.6% |
$3.03M +61.2% |
| Operating Income | -$19.05M -8.7% |
-$17.53M -26.3% |
-$13.88M +7.0% |
-$14.93M -103.4% |
-$7.34M -37.2% |
-$5.35M -107.5% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 53.71M +65.4% |
32.46M +196.5% |
10.95M +4.7% |
10.46M +66.0% |
6.30M -64.7% |
17.87M +0.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2018 | $0.00 | — | — |
| Net Income | December 31, 2025 | -$7.36M | -53.2% | +5.5% |
| Diluted EPS | December 31, 2025 | -$0.11 | +15.4% | +21.4% |
| Total Assets | December 31, 2025 | $10.26M | -15.6% | -20.9% |
| Cash and Equivalents | December 31, 2025 | $2.94M | -58.0% | -44.8% |
| Stockholders Equity | December 31, 2025 | $5.88M | -42.7% | -32.9% |
| R&D Expense | December 31, 2025 | $5.41M | +40.3% | -3.4% |
| Operating Income | December 31, 2025 | -$7.24M | -49.2% | +7.5% |
| Gross Profit | December 31, 2018 | $0.00 | — | — |
| Shares Outstanding | December 31, 2025 | 77.70M | +91.1% | +27.0% |
- Modular Medical, Inc. reported Total Revenue of $0.00 for fiscal year 2018.
- Modular Medical, Inc. reported Net Income of -$18.82 million for fiscal year 2025.
- Modular Medical, Inc. showed a decrease of -7.8% in Net Income compared to the prior fiscal year.
- Modular Medical, Inc. reported Diluted EPS of $0.51 per share (loss) for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +34.6% in Diluted EPS compared to the prior fiscal year.
- Modular Medical, Inc. reported Total Assets of $18.73 million for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +35.7% in Total Assets compared to the prior fiscal year.
- Modular Medical, Inc. reported Cash and Equivalents of $13.10 million for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +41.8% in Cash and Equivalents compared to the prior fiscal year.
- Modular Medical, Inc. reported Stockholders Equity of $17.08 million for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +48.0% in Stockholders Equity compared to the prior fiscal year.
- Modular Medical, Inc. reported R&D Expense of $14.70 million for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +14.1% in R&D Expense compared to the prior fiscal year.
- Modular Medical, Inc. reported Operating Income of -$19.05 million for fiscal year 2025.
- Modular Medical, Inc. showed a decrease of -8.7% in Operating Income compared to the prior fiscal year.
- Modular Medical, Inc. reported Gross Profit of $0.00 for fiscal year 2014.
- Modular Medical, Inc. reported Shares Outstanding of 53.71 million shares for fiscal year 2025.
- Modular Medical, Inc. showed an increase of +65.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: